A Phase 4 interventional study of drug eluting balloon and drug eluting stent in Stable Angina and Coronary Stenosis, sponsored by Aalborg University Hospital. Terminated at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2014-03-18.
Sponsored by Aalborg University Hospital · Phase 4, Interventional, and Treatment
A randomised open-label pilot study to assess the safety and efficacy of treatment with a drug eluting balloon alone in coronary de novo lesions). Elective patients requiring PCI to coronary de novo lesions in vessels 2.5 mm - 4.0 mm.
345 studies on the registry are indexed under Angina, Stable; 57 are open to participants now.
Browse Angina, Stable studies →Aalborg University Hospital is the lead sponsor of 195 studies on the registry; 39 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
drug eluting stent (Resolute)
Device: drug eluting stent
drug eluting balloon (Elutax)
Device: drug eluting balloon
Major adverse cardiac events
Time frame: 3 months
This study is terminated, as verified in Mar 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Aalborg University Hospital